Erbitux adds 5 weeks to lung cancer survival
June 1st, 2008
Debi wrote an interesting post today on
Here’s a quick excerpt
Lung cancer patients treated in a large clinical trial with ImClone Systems Inc’s Erbitux and chemotherapy lived about five weeks longer than patients treated with chemotherapy alone, according to study results released on Saturday.
Read the rest of this great post here
Posted in